GeneSite® has helped over 200,000 patients

September 24, 2015

Assurex Health, NCAF I company, has reached 200,000 patients with GeneSight®, which recommends a metal health treatment based on a patients genomic variants. The company has seen impressive results for patients and cost saving for insurance providers. Read the full press release here.


Comments are closed.